![Le Le Zhang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Le Le Zhang
Gründer bei
CUTIA THERAPEUTICS
Vermögen: 4 Mio $ am 31.07.2026
Profil
Le Le Zhang is the founder of Cutia Therapeutics, founded in 2019, holding the title of Chief Executive Officer & Executive Director since 2022.
The current job is General Manager & Director at Cutia Therapeutics (Shanghai) Co., Ltd. Education history includes a graduate degree from Shanghai Institute of Pharmaceutical Industry in 2005 and an undergraduate degree from Shenyang Pharmaceutical University in 2000.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUTIA THERAPEUTICS 4.01% | 03.11.2025 | 15’007’236 ( 4.01% ) | 4 Mio $ | 31.07.2026 |
Aktive Positionen von Le Le Zhang
| Unternehmen | Position | Beginn |
|---|---|---|
| CUTIA THERAPEUTICS | Gründer | 15.05.2019 |
Cutia Therapeutics (Shanghai) Co., Ltd.
 Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Vorstandsvorsitzender | - |
Ausbildung von Le Le Zhang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Shanghai Institute of Pharmaceutical Industry
 Shanghai Institute of Pharmaceutical Industry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cutia Therapeutics (Shanghai) Co., Ltd.
Cutia Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics to severe facial acne vulgaris | Health Technology |
Cutia Therapeutics
 Cutia Therapeutics Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing and marketing of dermatology based biopharmaceutical products | Health Technology |
